Zobrazeno 1 - 10
of 12
pro vyhledávání: '"James M. Camamo"'
Autor:
Richard A. Cosgrove, James M. Camamo, Christopher J Edwards, Asad E. Patanwala, Daniel H. Jarrell, Jessica DeAngelo
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(15)
Purpose Results of a comparison of blood product use and cost outcomes with use of 3-factor versus 4-factor prothrombin complex concentrate (PCC) for indications other than warfarin reversal are presented. Methods Consecutive patients who received 3-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c2ed6be1ae5924f0d3735e7060d494
https://pubmed.ncbi.nlm.nih.gov/29941507
https://pubmed.ncbi.nlm.nih.gov/29941507
Autor:
Sandra E. Kurtin, Kurt Weibel, Nikki L. Barket, Emad Elquza, Christopher J Campen, Ali McBride, Ravitharan Krishnadasan, Marie Maloney, Faiz Anwer, James M. Camamo, Daniel O. Persky
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 75(9)
Purpose Implementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting is described. Summary The University of Arizona Cancer Center and Banner–University Medical Center Tucson are affiliated not-for-profi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f0bee204f2d83200a03558c812ce71
https://pubmed.ncbi.nlm.nih.gov/29691269
https://pubmed.ncbi.nlm.nih.gov/29691269
Autor:
Daniel H. Jarrell, Richard A. Cosgrove, Asad E. Patanwala, James M. Camamo, Christopher J Edwards, Jessica DeAngelo
Publikováno v:
American journal of therapeutics. 25(3)
BACKGROUND Prothrombin complex concentrates (PCCs) are drug products containing varying amounts of vitamin K-dependent coagulation factors II, VII, IX, and X. The evidence comparing 3-factor PCC (3-PCC) versus 4-factor PCC (4-PCC) for warfarin revers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40fcc81242fba53662e125d57218ba0b
https://pubmed.ncbi.nlm.nih.gov/28763307
https://pubmed.ncbi.nlm.nih.gov/28763307
Autor:
Terence O'Keeffe, Brian L. Erstad, James M. Camamo, Conrad Diven, Brian J. Kopp, Kurt Weibel, Yvonne Huckleberry
Publikováno v:
Journal of Critical Care. 29:814-816
Purpose The purpose of this evaluation is to describe the cost savings associated with multimodal interventions aimed at reducing aerosolized bronchodilator use in mechanically ventilated patients without adversely affecting costs associated with len
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09eb0df8b0a394adad7f312571d3c13
https://doi.org/10.1016/j.jcrc.2014.05.016
https://doi.org/10.1016/j.jcrc.2014.05.016
Autor:
Muhammad Usman, Jemin Aby Jose, Sharoon Samuel, Ali McBride, Faiz Anwer, Awais Ijaz, Muhammad Junaid Tariq, Ali Younas Khan, Muhammad Jahanzeb Khalil, Muhammad Asad Fraz, Cara Chang, James M. Camamo, Insija Ilyas Selene, Malik Qistas Ahmad
Publikováno v:
Blood. 132:5667-5667
Introduction: Monoclonal antibody's infusion related reactions (IRRs) include anaphylaxis, anaphylactoid reactions and cytokine release syndrome. These reactions are related to the time of infusion. Incidence of IRRs in patients treated with daratumu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1002b412db08088b66258c4d6bd17ee
https://doi.org/10.1182/blood-2018-99-119736
https://doi.org/10.1182/blood-2018-99-119736
Publikováno v:
Pharmacotherapy. 25:184-190
Study Objectives. To determine whether use of inhaled alprostadil (PGE1) or epoprostenol (PGI2) significantly improved oxygenation in patients with acute respiratory distress syndrome (ARDS), and to determine whether differences between the two drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaad59371044303200d7bbe579383140
https://doi.org/10.1592/phco.25.2.184.56952
https://doi.org/10.1592/phco.25.2.184.56952
Publikováno v:
Annals of Pharmacotherapy. 38:641-648
OBJECTIVE To discuss the controversies regarding the use of epoetin alfa (EPO) for reducing red blood cell (RBC) transfusions in critically ill patients with anemia. DATA SOURCES A MEDLINE search (1966–July 2003) was conducted using the search term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18630872a016eff339f7b1d171e913c5
https://doi.org/10.1345/aph.1d368
https://doi.org/10.1345/aph.1d368
Publikováno v:
Critical Care Medicine. 25:1678-1684
To determine the appropriateness and medication cost of stress ulcer prophylaxis before and after a targeted educational intervention.In the preintervention cohort (phase 1), 264 patients were evaluated over 2 months, using stress ulcer prophylaxis g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ae936779988a46040191f6fc3e2b37
https://doi.org/10.1097/00003246-199710000-00017
https://doi.org/10.1097/00003246-199710000-00017
Autor:
Brian L. Erstad, James M. Camamo, Stuart N Bramblett, Jeremiah J. Duby, Yvonne Huckleberry, Jacob Abarca
Publikováno v:
BMC Blood Disorders, Vol 7, Iss 1, p 1 (2007)
BMC Blood Disorders
BMC Blood Disorders
Background The purpose of this study was to evaluate the impact of recombinant human erythropoietin (rHuEPO) use for anemia of critical illness at a practice site where delayed initiation is common. Methods Retrospective medical record review involvi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a590d74656dbe7874d727ce2c578d417
http://www.biomedcentral.com/1471-2326/7/1
http://www.biomedcentral.com/1471-2326/7/1
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 58(16)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4064b9a2fd157420c48849d1b8a0f1e4
https://pubmed.ncbi.nlm.nih.gov/11515349
https://pubmed.ncbi.nlm.nih.gov/11515349